AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
GlaxoSmithKline to allow second firm to make AIDS drugs in South Africa.
(From Agence France Presse)
The South African arm of GlaxoSmithKline, which has been rapped for inflating prices of its AIDS drugs, said it would allow a second manufacturer to produce generic versions of its antiretroviral (ARV) medicines.
The move will lead to a significant drop in AIDS drug prices, a top official of an independent competition watchdog said Wednesday.
The company also agreed to entertain applications from two more generic manufacturers, a company statement said, according to the SAPA news agency.
GlaxoSmithKline "has... agreed to entertain applications for a further two possible licences," the SAPA news agency quoted a …
-
- Boehringer Ingelheim licenses nevirapine in South Africa.
-
News wire article from: Asia Africa Intelligence Wire
October 23, 2002
700+ words
-
- Boehringer Ingelheim animal health closes deal to acquire a significant...
-
News wire article from: Chemical Business Newsbase
October 26, 2009
700+ words
-
- Boehringer Ingelheim Animal Health enters into agreement to acquire certain...
-
News wire article from: Chemical Business Newsbase
September 21, 2009
700+ words
-
- Boehringer Ingelheim Animal Health closes deal to acquire a significant...
-
News wire article from: Chemical Business Newsbase
October 26, 2009
700+ words
-
- Boehringer Ingelheim launches PROUD study to explore possible...
-
News wire article from: Chemical Business Newsbase
October 31, 2006
700+ words
